CanPath Announces its 2023-2027 Strategic Plan
The Canadian Partnership for Tomorrow’s Health (CanPath) is excited to announce its 2023-2027 Strategic Plan! The four key objectives of this plan will guide CanPath’s […]
CanPath Awarded $1.1 million CIHR Grant for COVID-19 and Cancer Research Project
The PREPARE-Canada initiative will capture the impact of COVID-19 on cancer outcomes in Canada and the impact of COVID-19 on modifying cancer risk in the […]
20 years of Alberta’s Tomorrow Project
Alberta’s largest research platform reflects on two decades since its inception Alberta’s Tomorrow Project (ATP) launched in 2001, making history as the province’s largest health research […]
CanPath to study the impact and immune response to COVID-19 infection and vaccination
The Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study is expanding. The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task […]
Early results from CanPath’s national study confirm antibody levels are stronger after receiving two doses of COVID-19 vaccine
Initial preliminary results from the Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study, based on close to 6,000 dried blood spot samples collected between […]
CanPath Whole Genome Sequencing Initiatives
With a biobank containing biospecimens from over 150,000 participants from across Canada, CanPath is a valuable platform for genomics research in Canada and globally. To […]
New Round of Linkage of CANUE Environmental Datasets to CanPath Data
A second round of Canadian Urban Environmental Health Research Consortium (CANUE) environmental exposure datasets have been linked with the national harmonized CanPath datasets and were […]
Dr. Robin Urquhart named Scientific Director of Atlantic PATH
CanPath has named Dr. Robin Urquhart have named Dr. Robin Urquhart the new Scientific Director of the Atlantic regional cohort – the Atlantic Partnership for Tomorrow’s Health Study (Atlantic PATH).
National COVID-19 Questionnaire Data Now Available
Over 101,500 CanPath participants from across Canada completed the CanPath COVID-19 Questionnaire in 2020. The first release of this data, including the over 93,000 responses […]
Canada’s COVID-19 Immunity Task Force funds national CanPath study looking at seroprevalence of COVID-19 antibodies among high-risk populations
The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task Force (CITF) to fund a Canadian Partnership for Tomorrow’s Health (CanPath) study […]